None listed
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) Male and females under the age of 80 2) Those who have been diagnosed with Parkinson's disease within the last 5 years 3) MMSE-K (Mini-Mental State Exam) score of 20 or higher and the ability to understand the questionnaire contents in person or through a guardian 4) A person who has voluntarily consented in a written informed consent form either on his or her behalf or on behalf of his or her legal representative
Exclusion criteria
Exclusion criteria: 1) Those who have been diagnosed with secondary or atypical Parkinsonism 2) If the MMSE-K (Mini-Mental State Examination) score is less than 20 3) Those who are taking treatment for metabolic, psychiatric, or neurological diseases (diabetes, hypertension, cardiovascular disease, liver or kidney disease, and so on) that may interfere with study compliance or safety 4) Those who have difficulty walking and moving as a result of other musculoskeletal disorders 5) If participation in this clinical study is not suitable according to the judgment of the researcher
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| UPDRS(Unified Parkinson’s Disease Rating Scale) | — |
Secondary
| Measure | Time frame |
|---|---|
| fNIRS(Functional near-infrared spectroscopy);GAITRite(GAITRite Electronic Walkway Platinum);Gut microbiome diversity;EQ-5D(health-related quality of life questionnaire);EQ-VAS(Visual Analog Scale) | — |
Countries
Korea, Republic of
Contacts
Daejeon Korean Medicine Hospital of Daejeon University